共 50 条
Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay
被引:34
|作者:
Goldenberger, Daniel
[1
,2
]
Leuzinger, Karoline
[3
]
Sogaard, Kirstine K.
[1
,2
,4
]
Gosert, Rainer
[3
]
Roloff, Tim
[1
,2
,4
]
Naegele, Klaudia
[3
]
Cuenod, Aline
[4
]
Mari, Alfredo
[4
]
Seth-Smith, Helena
[1
,2
,4
]
Rentsch, Katharina
[5
]
Hinic, Vladimira
[1
,2
]
Hirsch, Hans H.
[3
,6
,7
]
Egli, Adrian
[1
,2
,4
]
机构:
[1] Univ Hosp Basel, Lab Med, Clin Bacteriol & Mycol, Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Univ Hosp Basel, Lab Med, Clin Virol, Basel, Switzerland
[4] Univ Basel, Dept Biomed, Lab Med, Appl Microbiol Res, Basel, Switzerland
[5] Univ Hosp Basel, Lab Med, Basel, Switzerland
[6] Univ Hosp Basel, Infect Dis & Hosp Epidemiol, Basel, Switzerland
[7] Univ Basel, Dept Biomed, Transplantat & Clin Virol, Basel, Switzerland
关键词:
SARS-CoV-2;
COVID-19;
GeneXpert;
Respiratory infection;
Viruses;
Diagnostics;
PCR;
NAT;
COBAS;
6800;
D O I:
10.1016/j.jviromet.2020.113925
中图分类号:
Q5 [生物化学];
学科分类号:
071010 ;
081704 ;
摘要:
The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a range of SARS-CoV-2 loads and across established human coronaviruses.
引用
下载
收藏
页数:3
相关论文